22 unchanged sentences
2019 Equity Incentive Plan (the “2019 Plan”).
−Removed: The 2019 Plan provides for grants to directors, employees and consultants of our company and operating partnership, including options, restricted stock, restricted stock units, stock appreciation rights, performance awards, dividend equivalents and other equity-based awards, including LTIP units.
+Added: The 2019 Plan provides for grants to directors, employees and consultants of our Company and ESRT, including options, restricted stock, restricted stock units, stock appreciation rights, performance awards, dividend equivalents and other equity-based awards, including LTIP units.
An aggregate of approximately 11.0 million shares of our common stock are authorized for issuance under awards granted pursuant to the 2019 Plan.
3 unchanged sentences
The shares of Class A common stock underlying any awards under the 2019 Plan and the 2013 Plan that are forfeited, canceled or otherwise terminated, other than by exercise, will be added back to the shares of Class A common stock available for issuance under the 2019 Plan.
−Removed: For a further discussion of the Plans, see "Financial Statements - Note 10 Capital".
+Added: For a further discussion of the Plans, see "Financial Statements - Note 10 Capital" in this Annual Report on Form 10-K.
The following table presents certain information about our equity compensation plans as of December 31, 2023:
21 unchanged sentences
Repurchases of Equity Securities Stock and Publicly Traded Operating Partnership Unit Repurchase Program
−Removed: ESRT's Board of Directors authorized the repurchase of up to $500 million of our Class A common stock and the Operating Partnership’s Series ES, Series 250 and Series 60 operating partnership units during the period from January 1, 2022 through December 31, 2023.
−Removed: This replaces an earlier $500.0 million repurchase authorization that ran from January 1, 2021 through December 31, 2021.
−Removed: Under the program, we may purchase our Class A common stock and the Operating Partnership’s Series ES, Series 250 and Series 60 operating partnership units in accordance with applicable securities laws from time to time in the open market or in privately negotiated transactions.
+Added: ESRT's Board of Directors authorized the repurchase of up to $500 million of ESRT's Class A common stock and our Series ES, Series 250 and Series 60 operating partnership units during the period from January 1, 2022 through December 31, 2023.
+Added: Upon expiration of this program, ESRT's Board of Directors authorized the repurchase of up to $500 million of ESRT's Class A common stock and our Series ES, Series 250 and Series 60 operating partnership units during the period from January 1, 2024 through December 31, 2025.
+Added: Under the program, ESRT may purchase its Class A common stock and we may purchase our Series ES, Series 250 and Series 60 operating partnership units in accordance with applicable securities laws from time to time in the open market or in privately negotiated transactions.
The timing, manner, price and amount of any repurchases will be determined by us and will be subject to stock price, availability, trading volume, general market conditions, and applicable securities laws.
−Removed: The authorization does not obligate us to acquire any particular amount of securities, and the program may be suspended or discontinued at our discretion without prior notice.
−Removed: As of December 31, 2022, we had approximately $409.8 million remaining of the authorized repurchase amount.
−Removed: The following table summarizes our purchases of equity securities in each of the three months in the three month period ended December 31, 2022 under the repurchase program described above:
−Removed: Period Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plan Maximum Approximate Dollar Value Available for Future Purchase (in thousands)
−Removed: October 1-31, 2022 313,530 $ 6.60 313,530 $ 415,384
−Removed: November 1-30, 2022 — $ — — $ —
−Removed: December 1-31, 2022 824,684 $ 6.74 824,684 $ 409,824
+Added: The authorization does not obligate ESRT or us to acquire any particular amount of securities, and the program may be suspended or discontinued at ESRT's and our discretion without prior notice.
+Added: At December 31, 2023, ESRT had used approximately $103.3 million of the authorized repurchase amount for the 2022-2023 period.
+Added: There were no repurchases of equity securities in the three-month period ended December 31, 2023 under this repurchase program.
+Added: See "Financial Statements - Note 10 Capital" in this Annual Report on Form 10-K.
+Added: There have also been no repurchases of equity securities yet under the new repurchase program.
Not applicable.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.